Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting human dendritic cells in situ to improve vaccines.

Immunology letters - 1 Nov 2014

Sehgal Kartik, Dhodapkar Kavita M, Dhodapkar Madhav V

Abstract excerpt

Dendritic cells (DCs) provide a critical link between innate and adaptive immunity. The potent antigen presenting properties of DCs makes them a valuable target for the delivery of immunogenic cargo. Recent clinical studies describing in situ DC targeting with antibody-mediated targeting of DC receptor through DEC-205 provide new opportunities for the clinical application of DC-targeted vaccines. Further advances...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Antigen Presentation
Share to Antigen-Presenting Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens

Share to Dendritic Cells

Share to Nanoparticles

Share to Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 25072116
DOI: 10.1016/j.imlet.2014.07.004
PMCID: PMC4506641

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting human dendritic cells in situ to improve vaccines.PMID 25072116Read ↗

Refining Dendritic Cell-Based Cancer Vaccines: Subset Targeting, Translational Barriers, and Emerging StrategiesSemantic proximity Read ↗

Phenotypes and Functions of Human Dendritic Cell Subsets in the Tumor Microenvironment.Semantic proximity Read ↗

Rewiring dendritic cell function with CLEC9A and DEC205-based chimeric antigen receptorsSemantic proximity Read ↗

Dendritic Cells and Their Role in Immunotherapy.Semantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitroSemantic proximity Read ↗

Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional AnalysesSemantic proximity Read ↗

Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Semantic proximity Read ↗

Active immunization against cancer with dendritic cells: the near future.Semantic proximity Read ↗

Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies.Semantic proximity Read ↗

Dendritic cells in vivo and in vitro.Semantic proximity Read ↗

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.